You should follow Eddy Elfenbein on Twitter, he’s a funny and interesting guy. But you shouldn’t sign up for his newsletter just to learn a “secret” stock pick. I’m not picking specifically on Elfenbein there, of course, just my regular public service announcement that sending money to someone to learn about a stock pick that […]
Articles
We’ve all seen the stories about Disney+ and HBO NOW and the other direct and “over the top” (OTT) streaming services that content providers are hoping will replace their shrinking cable income… and, of course, about whether or not Netflix can remain at the top of the heap among the streaming providers… … so it’s […]
Promises a “balanced portfolio approach to high and medium growth stock investing,” with a core of large cap “steady growth” positions and some smaller or more speculative stocks. Previously edited by Bret Jensen and Tony Daltorio.
Focused on “using the relative safety of dividend stocks to execute conservative options trades.” Edited by Tim Plaehn, who runs several dividend-related services including The Dividend Hunter.
Service that is “looking for breakout returns from the exciting biotech sector.” Monthly issues/recommendations with weekly updates.
“1,416 miles from the hucksters on Wall Street, one unheard-of “specialty bank” is breaking every rule of modern banking and actually paying its members a fair yield of 7% annually… “And despite the fact that this has been kept quiet for years now, some of the biggest banks and mutual funds are reaping huge profits […]
High-yield and dividend-growth focused newsletter, offering the “monthly dividend paycheck calendar” and attempting to pick stocks from companies who can sustain a high and growing dividend.
New letter launched in 2014, focuses on building a portfolio of small capitalization stocks.
Comments
Stansberry research Tim Phaeln at investors alley Contrarian outlook...
I have been disappointed in Fitzg's newsletter. But I have picked up good advice from Tim Plaehn's Investors' Alley. He...
From Bret Jensen of Investors Alley: Amicus Therapeutics (NASDAQ: FOLD), another attractive small biotech concern se...
Well, thats a switch. Ordinarily I'd say I've gotten some of the worst advice from Investors Alley in the last year....
I still subscribe to The Oxford Income Letter. It's still okay and I do like reading their take on the markets. I am al...
Change of subject, I received an email from Investor's Alley saying that 19 major banks to shut down. Do you have any c...
(Do your own Due Diligence: No position in either company - KennyG) 2 Attractive Small-Cap Biotech Stocks On The Verge ...
Hi Rae: I happened to be awake because the any-minute coming of Santa Claus excites me. $EW is a classy company whose...
$EW Dr. KSS what is your opinion of $EW - Edwards Lifesciences. It quietly goes about its business with very little p...